HTGC News Alert Hercules Technology Growth Capital (HTGC) 15.13

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 8:51 PM

Hercules Technology Growth Capital (HTGC) 15.13 $HTGC

Hercules Surpasses its 2014 New Origination Growth Target - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 9:30AM CST
Hercules (HTGC) released its portfolio update for fourth-quarter 2014, which reflected sturdy loan origination performance.
MVNR: 13.10 (-0.10), HTGC: 15.13 (+0.39), PGI: 10.55 (+0.01), AVG: 20.25 (+0.18)

Top 10 BDC Issues For 2015: Part 2
BDC Buzz - at Seeking Alpha - Tue Dec 23, 4:42PM CST

NMFC: 14.85 (-0.06), PNNT: 9.53 (-0.18), HTGC: 15.13 (+0.39), MAIN: 30.13 (+0.19), TCAP: 20.45 (+0.03), FULL: 4.76 (-0.01), TICC: 7.60 (+0.01), GBDC: 18.02 (+0.02), PFLT: 13.85 (+0.05), TCPC: 16.24 (-0.23), TPVG: 14.78 (+0.16), ARCC: 15.86 (+0.07), FSC: 8.08 (+0.01), AINV: 7.55 (-0.01), TSLX: 16.85 (+0.12), MCC: 9.18 (-0.11), KCAP: 6.95 (-0.27), FDUS: 15.11 (+0.24), PSEC: 8.59 (-0.02), FSIC: 10.06 (+0.01)

Hercules Technology updates on Q4 activity
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 3:39PM CST

HTGC: 15.13 (+0.39)

Hercules Technology Growth Capital Achieves ~$900.0 Million of New Origination Commitments for 2014 - A Historical Record Level
Business Wire - Tue Dec 23, 3:05PM CST
--2014 year-to-date new origination commitments of approximately $900.0 million surpasses 2013 commitments of $705.0 million - a 28% increase
HTGC: 15.13 (+0.39), MVNR: 13.10 (-0.10), PGI: 10.55 (+0.01), ZAYO: 31.48 (+0.28), PRTK: 37.70 (+1.30), AVG: 20.25 (+0.18), ICLD: 3.00 (-0.02), GIS: 54.31 (-0.10)

Insider Trading Alert - HTGC, KFY And FNGN Traded By Insiders
at The Street - Tue Dec 23, 10:15AM CST
Stocks with insider trader activity include HTGC, KFY and FNGN
FNGN: 37.85 (+0.79), HTGC: 15.13 (+0.39), KFY: 29.41 (+0.12)

High Yield 50/50 Portfolio Strategy Built With BDCs And MREITs.
High Yield Investor - at Seeking Alpha - Mon Dec 22, 9:25AM CST

WGL: 54.00 (+0.89), STR: 25.39 (+0.29), RSO: 5.29 (-0.03), HCP: 44.00 (-0.45), HTGC: 15.13 (+0.39), CLX: 105.46 (-0.62), AGNC: 22.14 (-0.08), XOM: 93.78 (-0.81), HTS: 18.38 (-0.26), MO: 50.36 (-0.17), NYMT: 7.71 (-0.06), T: 33.96 (-0.07), NLY: 11.21 (-0.05), ARCC: 15.86 (+0.07), FSC: 8.08 (+0.01), AINV: 7.55 (-0.01), TGT: 74.65 (-0.04), MCD: 93.83 (-0.39), CVX: 113.47 (-0.48), PSEC: 8.59 (-0.02)

Who's Really Getting Rich in High-Yield Stocks?
Jordan Wathen, The Motley Fool - Motley Fool - Thu Dec 18, 12:00PM CST
Financial ratios rarely tell all. A high return on equity is often the product of too much debt. Similarly, an inflated dividend payout ratio might owe to a goodwill writedown in a single year, which reduces the denominator: income. All the same,...
MAIN: 30.13 (+0.19), HTGC: 15.13 (+0.39), TCAP: 20.45 (+0.03), ARCC: 15.86 (+0.07), FSC: 8.08 (+0.01), MCC: 9.18 (-0.11), GBDC: 18.02 (+0.02), PSEC: 8.59 (-0.02)

ADMA Biologics Receives $5M Tranche From Hercules Technology Growth Capital
GlobeNewswire - Mon Dec 15, 7:08AM CST
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that it has received a $5 million tranche from Hercules Technology Growth Capital, Inc. (NYSE:HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets. The $5 million was based upon ADMA achieving clinical endpoints of a Phase III clinical study of RI-002 as a treatment for Primary Immunodeficiency Disease (PIDD), under its existing loan and security agreement.
HTGC: 15.13 (+0.39), ADMA: 10.98 (-0.12)

High-Yield BDCs Hit New Lows
BDC Buzz - at Seeking Alpha - Mon Dec 15, 5:11AM CST

GLAD: 8.55 (+0.05), TCPC: 16.24 (-0.23), MAIN: 30.13 (+0.19), HTGC: 15.13 (+0.39), FULL: 4.76 (-0.01), BKCC: 8.15 (unch), BDCL: 21.89 (+0.34), FSC: 8.08 (+0.01), TSLX: 16.85 (+0.12), MCC: 9.18 (-0.11), KCAP: 6.95 (-0.27), GBDC: 18.02 (+0.02), PSEC: 8.59 (-0.02)

Dover Corporation And How Do You Rank Your Holdings?
Dividend Sleuth - at Seeking Alpha - Sun Dec 14, 10:35PM CST
A Growing Safety Consciousness Safety of dividend income has become a stronger priority for me due to the longevity of this bull market and the volatility caused by the recent precipitous drop in oil prices. Diversification is an important factor...
WGL: 54.00 (+0.89), KMI: 42.01 (+0.10), MMM: 166.96 (+0.09), HCP: 44.00 (-0.45), HTGC: 15.13 (+0.39), TCAP: 20.45 (+0.03), GPC: 107.62 (-0.21), NNN: 40.27 (+0.15), EMR: 62.73 (-0.10), HP: 67.25 (-0.66), O: 49.42 (+0.33), WEC: 53.56 (+1.08), TUP: 63.02 (+0.14), PEP: 97.09 (-0.27), STWD: 23.42 (-0.21), T: 33.96 (-0.07), HASI: 14.11 (-0.15), JNJ: 104.59 (+0.31), NWN: 50.03 (+0.47), LNCO: 10.87 (-0.44), WPC: 72.47 (-0.07), MCD: 93.83 (-0.39), DOV: 74.20 (-0.28), PG: 93.14 (-0.15), CVX: 113.47 (-0.48)

Tax-Loss Harvesting For BDCs
BDC Buzz - at Seeking Alpha - Sun Dec 07, 5:56PM CST

NMFC: 14.85 (-0.06), HTGC: 15.13 (+0.39), MAIN: 30.13 (+0.19), TCAP: 20.45 (+0.03), BKCC: 8.15 (unch), FULL: 4.76 (-0.01), TICC: 7.60 (+0.01), SUNS: 14.99 (-0.25), BDCS: 23.15 (-0.78), GBDC: 18.02 (+0.02), PFLT: 13.85 (+0.05), GLAD: 8.55 (+0.05), TCPC: 16.24 (-0.23), SPY: 207.77 (+0.02), BDCL: 21.89 (+0.34), ARCC: 15.86 (+0.07), FSC: 8.08 (+0.01), TSLX: 16.85 (+0.12), MCC: 9.18 (-0.11), KCAP: 6.95 (-0.27), BIZD: 18.53 (+0.05), FDUS: 15.11 (+0.24), PSEC: 8.59 (-0.02), FSIC: 10.06 (+0.01)

Insider Trading Alert - AWAY, LCI And HTGC Traded By Insiders
at The Street - Thu Dec 04, 10:45AM CST
Stocks with insider trader activity include AWAY, LCI and HTGC
LCI: 42.29 (+1.79), HTGC: 15.13 (+0.39), AWAY: 28.87 (+0.05)

Insider Trading Alert - HTGC, MBRG And SPH Traded By Insiders
at The Street - Wed Nov 26, 11:26AM CST
Stocks with insider trader activity include HTGC, MBRG and SPH
HTGC: 15.13 (+0.39), SPH: 43.14 (-0.20), MBRG: 18.00 (-0.16)

Institutional Ownership Changes For BDCs
BDC Buzz - at Seeking Alpha - Wed Nov 26, 4:43AM CST

NMFC: 14.85 (-0.06), HTGC: 15.13 (+0.39), MAIN: 30.13 (+0.19), TCAP: 20.45 (+0.03), SLRC: 18.01 (-0.02), BKCC: 8.15 (unch), SUNS: 14.99 (-0.25), GBDC: 18.02 (+0.02), PFLT: 13.85 (+0.05), GLAD: 8.55 (+0.05), TCPC: 16.24 (-0.23), ARCC: 15.86 (+0.07), FSC: 8.08 (+0.01), AINV: 7.55 (-0.01), TSLX: 16.85 (+0.12), KCAP: 6.95 (-0.27), PSEC: 8.59 (-0.02), FSIC: 10.06 (+0.01)

BDC Leverage And Interest Expense Coverage
BDC Buzz - at Seeking Alpha - Mon Nov 24, 1:40AM CST

NMFC: 14.85 (-0.06), HTGC: 15.13 (+0.39), MAIN: 30.13 (+0.19), PNNT: 9.53 (-0.18), TCAP: 20.45 (+0.03), SLRC: 18.01 (-0.02), BKCC: 8.15 (unch), GBDC: 18.02 (+0.02), GLAD: 8.55 (+0.05), TCPC: 16.24 (-0.23), ARCC: 15.86 (+0.07), FSC: 8.08 (+0.01), MCC: 9.18 (-0.11), FDUS: 15.11 (+0.24), PSEC: 8.59 (-0.02), FSIC: 10.06 (+0.01)

Insider Trading Alert - PPBI, KLIC And HTGC Traded By Insiders
at The Street - Fri Nov 21, 12:30PM CST
Stocks with insider trader activity include PPBI, KLIC and HTGC
KLIC: 14.56 (-0.11), HTGC: 15.13 (+0.39), PPBI: 16.80 (-0.12)

Genocea secures new capital
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 8:40AM CST

HTGC: 15.13 (+0.39), GNCA: 7.42 (-0.11)

Genocea Secures Debt Facility from Hercules Technology Growth Capital of up to $27 Million
Business Wire - Fri Nov 21, 7:30AM CST
Genocea Biosciences, Inc. (NASDAQ:GNCA), a company developing T cell-directed vaccines and immunotherapies, today announced that it has entered into a loan and security agreement with Hercules Technology Growth Capital, Inc. (NYSE:HTGC) for a term loan of up to $27.0 million.
HTGC: 15.13 (+0.39), GNCA: 7.42 (-0.11)

BDC Results For Q3 2014
BDC Buzz - at Seeking Alpha - Sun Nov 16, 10:30AM CST

HTGC: 15.13 (+0.39), MAIN: 30.13 (+0.19), PNNT: 9.53 (-0.18), TCAP: 20.45 (+0.03), BKCC: 8.15 (unch), FULL: 4.76 (-0.01), TICC: 7.60 (+0.01), SUNS: 14.99 (-0.25), GBDC: 18.02 (+0.02), HRZN: 13.92 (-0.07), GLAD: 8.55 (+0.05), TCPC: 16.24 (-0.23), TCRD: 11.51 (-0.05), FSC: 8.08 (+0.01), AINV: 7.55 (-0.01), MCGC: 3.95 (+0.02), TSLX: 16.85 (+0.12), MCC: 9.18 (-0.11), PSEC: 8.59 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blue Moon Metals Gears Up for Springer Mine Revamp

Getting Set for a Big Move Blue Moon Metals Inc. isn't sitting around with its thumbs in its pockets. The company has made some strides with their Springer Tungsten Mine project in Imlay, Nevada. Let's break down what these folks are up to. Refurbished Up for the Fast Track The rock mover here is the refurbishment of the Springer processing plant. You don't just snap your...

ASICS and University of Michigan Launch Innovation Lab

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Boscia's Future Ties Tradition and Modern Science

Reviving a Skincare Legacy With the wind of innovation at its back, The Center Brands and Dr. Mamina Turegano are stepping in to breathe new life into Boscia. Now, I'm not just talking about a simple facelift. We're talking about an all-out integration of traditional Japanese skincare principles with the sharp edge of modern dermatologic science. It's a brave move...

University of Phoenix Grads Gain High Praise from Managers

Forget the stereotypes that tag University of Phoenix as just another factory for diplomas. The latest survey results paint a picture of graduates who seem to be real go-getters in the workplace. We’ve got managers from all over singing the praises of these alums, with a whopping 96% ready to vouch for them stepping into bigger roles. Not just talk, folks, this is their...

Elbit Systems Lands $200M APAC ISTAR Contracts

By Ryan Hughes Updated Oct 26, 2026 Category News Views 100

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Medline's Decade-Long WRAP Partnership: More Than Labels

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

Gentex Faces Investigation as Shares Tumble 7%

Investigating Gentex's Financial Setback Gentex Corporation, ticker NASDAQ:GNTX, is caught in a bit of a blizzard right now. Their shares took a nosedive, down 7%, after some messy numbers came out in their third-quarter report—tariffs and the kind of pricing pressure that makes grown investors wince. If you threw your chips in on Gentex and got burned, the lawyers are...

MacDonald Steps Up as President at California Bank

New Leadership at California Bank & Trust It's a big shakeup in the banking lanes today as Michael MacDonald grabs the helm at California Bank & Trust (CB&T). He's stepping into the President's shoes, bringing along a toolkit of experience and know-how that's tough to find elsewhere. Under his watch, CB&T aims to blend the nimble maneuvering of local banks with the clout...